Skip to content
Governance Register

← US public companies

Serina Therapeutics, Inc.

SEC CIK 1708599 · SER · last insider filing 2026-06-22

Directors (from insider filings)

NameCapacity as filedFilings
Wilson Karen J Director filed 2025 - 2026
Bailey Gregory Director filed 2018 - 2026
Venkatesan Jay Director filed 2025 - 2026
Brannan Stephen K. Director filed 2025 - 2026
Marshall Richard Peter Director filed 2024 - 2026
Ledger Steven A Director · Interim CEO filed 2024 - 2026
Gill Simba Director filed 2024 - 2026
Juvenescence Ltd Director filed 2018 - 2025
Mintz Steven Director filed 2024 - 2024
Harris J Milton Director filed 2024 - 2024
Gross Remy Director filed 2024 - 2024
Renondin Jean-Christophe Director filed 2023 - 2023
Juvenescence US Corp. Director filed 2023 - 2023
West Michael D Director · Chief Executive Officer filed 2018 - 2023
Hackett Joanne M. Director filed 2022 - 2022
Jenkins Annalisa Director filed 2018 - 2021
MAY Michael H Director filed 2019 - 2021
Mauldin John F Director filed 2018 - 2019
Mulroy Michael H. Director filed 2018 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Curhan Gregory S Chief Financial Officer filed 2024 - 2026
Moreadith Randall Chief Scientific Officer filed 2024 - 2026
Tenjarla Srini SVP, CMC & Formulation filed 2024 - 2026
Viegas Tacey COO and Secretary filed 2024 - 2024
Segall Judith Director, Admin & Secretary filed 2018 - 2021
Malik Nafees Naseer Chief Operating Officer filed 2018 - 2021
Park Andrea Eun Jae Chief Financial Officer filed 2020 - 2021
Sternberg HAL Vice President-Research filed 2018 - 2021
Skibsted Russell Chief Financial Officer filed 2018 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.